Immune Surveillance: What the Cancer-Adjacent Labs Measure

Immune surveillance: the patrol your body already runs

Start with the biology, because it is the part almost nobody is taught. Every day your cells divide, wear out, take small hits from ordinary metabolism, and occasionally make mistakes copying themselves. Most of those mistakes are caught and fixed inside the cell, or the cell quietly retires itself. The immune system provides a second layer over the top of that: a routine housekeeping patrol, running constantly, that recognises cells displaying the wrong signals -- damaged, infected, senescent, or simply abnormal -- and removes them. Scientists call this immune surveillance, and it is normal physiology, the same way your kidneys filtering blood is normal physiology. Two cell types do much of this frontline work. Natural killer (NK) cells are the fast-acting arm of the innate immune system -- they do not need to be shown a specific target in advance; they patrol and act on cells that look wrong. T cells, and cytotoxic CD8 T cells in particular, are the more targeted, trained arm -- they learn specific signatures and remember them. A 2026 review of diet and long-term oncological outcomes describes exactly this framing, connecting the body's oxidative and inflammatory burden to how well immune surveillance functions.[1] Here is why that matters for a lab conversation. This patrol is not a fixed setting. It is shaped by nutrient status, by how much chronic inflammation a body is carrying, by sleep, stress, and age. Vitamin D, for instance, acts directly on immune cells: the vitamin D receptor sits on T cells and influences how they develop and respond, which is straightforward structure-and-function biology.[7] So when we talk about "supporting the immune system," we are not being vague -- we are talking about measurable inputs to a patrol the body is already running. Our view, stated as our own: this is the honest centre of the whole topic. The useful conversation is not "how do I test for cancer at home" -- you cannot, and anyone selling that is overreaching. The useful conversation is "how does my body's normal defence and repair machinery work, and what can I actually measure about the conditions it runs in."

The panel is not what most people think it is

Now the panel itself, described honestly, because the name misleads people. The grouping often called a "cancer" or "cancer-adjacent" panel is, in our lab library, labelled Oncology-Adjacent -- and the definition matters: these are markers ordered and interpreted WITH an oncology team, for monitoring and supportive care. They are not screening tests, and nothing on the panel substitutes for that team. That single sentence resolves most of the confusion. Roughly half the panel is tumour markers -- proteins or genetic material that a clinician tracks in someone who already has a diagnosis, to watch how a known situation is behaving over time. These include PSA (prostate-specific antigen), CA-125, CA 19-9, CEA (carcinoembryonic antigen), AFP (alpha-fetoprotein), the breast-associated markers CA 15-3 and CA 27.29, beta-hCG, and LDH (lactate dehydrogenase), alongside newer tools such as circulating tumour DNA (ctDNA) liquid biopsy, multi-cancer early-detection tests, and circulating tumour cells. The critical, repeated point about that half: these are not self-interpreted, and a single number in isolation does not tell a person whether they have cancer. They are monitoring instruments a clinical team reads in full context. We are naming them so you understand what is on the panel -- not so you read your own printout and draw a conclusion, which is exactly the thing this page exists to prevent. The other half of the panel is completely different in character, and it is the half this article can actually teach. It measures terrain: the inflammatory, metabolic, oxidative, and nutritional conditions a body is carrying. Those markers are hs-CRP, fasting insulin and IGF-1, GGT, homocysteine, and vitamin D. They are studied for their association with risk at a population level, and -- unlike the tumour markers -- they describe modifiable, understandable biology. That is where we spend the rest of this piece. Education only, not medical advice. Which markers, if any, apply to a given person is a clinician's call, always.

The terrain half, marker by marker

Here is what each terrain marker actually measures, in plain terms, and why it sits on a panel like this. Each is described as structure-and-function biology and as cited research -- none is a cancer test, and none is a target to chase alone. hs-CRP (high-sensitivity C-reactive protein) is a liver-made marker of systemic inflammation. It is on the panel because chronic low-grade inflammation is a recognised part of the terrain that research studies in relation to cancer risk -- a meta-analysis of prospective studies found a modest association between elevated hs-CRP and overall cancer risk at a population level.[2] The honest caveat travels with it: hs-CRP also rises with any recent infection, injury, or hard training session, so a single high value is not meaningful on its own, and it is emphatically not a cancer test for an individual. Fasting insulin and IGF-1 are the metabolic-signalling pair. Fasting insulin reflects how hard the body is working to keep blood sugar normal; IGF-1 is a growth-signalling hormone set partly by growth hormone and partly by protein and calorie intake. They are studied together because insulin and IGF-1 signalling drive cell growth and division. Stated honestly, as the research does: a Mendelian randomisation study linked genetically higher fasting insulin to increased risk of specific cancers, colorectal and endometrial, with no clear association across all sites,[3] and a companion analysis supported a causal association between higher IGF-1 and colorectal cancer risk while remaining inconclusive for prostate and breast.[4] Neither is a number to drive to an "optimal" value with supplements -- IGF-1 is also essential for normal muscle and bone, and there is no validated target for a healthy adult. GGT (gamma-glutamyl transferase) is a liver enzyme most people meet in an alcohol context, but on this panel it sits as an oxidative-stress marker. It is, in effect, the glutathione marker hiding in a liver panel -- the enzyme's job involves recycling glutathione, the body's central antioxidant, so a rising GGT tracks oxidative burden. It is nonspecific and heavily influenced by alcohol, medications, and metabolic health, so it prompts a broader look, not alarm. Homocysteine is an amino-acid by-product cleared by B12-, folate-, and B6-dependent pathways, which makes it a useful window on B-vitamin status. Its link to cancer is genuinely more mixed and less consistent than its cardiovascular story, and kidney function raises it independently -- so it is not a stand-alone risk marker. Vitamin D gets its own section below, because its evidence deserves a careful, two-sided read rather than a headline.

Chronic inflammation as measurable terrain

Of everything on the terrain half, inflammation is the thread that ties the panel back to immune surveillance, so it is worth sitting with. The immune patrol works best in a body that is not permanently inflamed. Acute inflammation is the immune system doing its job -- responding to an injury or an infection and then resolving. Chronic low-grade inflammation is different: a background hum that never fully switches off, and it is a recognised feature of the terrain studied in relation to many chronic conditions. hs-CRP is the routine, affordable way to see that hum on a lab report,[2] which is why it earns a place next to the tumour markers even though it is nothing like them in kind. The mechanism angle is what makes this actionable in an educational sense. Chronic inflammation and oxidative stress are exactly the conditions that a well-functioning immune surveillance system has to work against, and the research on diet and oncological outcomes frames protective eating patterns precisely in those terms -- as lowering oxidative and inflammatory burden and supporting immune surveillance.[1] That is a structure-and-function statement about the body's normal defences, not a claim that any food prevents a disease. Our view: this is the reframe that makes the whole topic less frightening and more useful. You cannot measure "my cancer risk" on a home panel, and you should not try. You can, with a clinician, measure the terrain -- how inflamed, how metabolically strained, how oxidatively burdened, how nutrient-replete a body is -- and those are conditions the body's own patrol is sensitive to.

Nutrient status and the immune patrol

If immune surveillance is the patrol, a handful of nutrients are among the raw materials it runs on. We describe these by mechanism and by their role in NORMAL immune function -- not one of them treats, cures, or prevents any disease, and none is a stand-alone fix. Vitamin D is the clearest example of a nutrient welded into immune function. Beyond bone health, the vitamin D receptor is present on T cells and directly influences how those immune cells develop and respond -- established structure-and-function biology.[7] Correcting a genuine vitamin D deficiency is worth doing on its own merits, for bone, muscle, and immune function, and that is a better reason than any risk headline. Zinc is the next. It is required across immune-cell function, and a randomised trial in young adults found that short-term zinc supplementation enhanced natural killer cell functionality -- a direct link between a common dietary shortfall and the innate arm of the very patrol this article opened with.[8] Zinc is also one of the more common quiet shortfalls in a modern diet. Selenium sits in the same conversation as a component of the body's antioxidant enzyme systems, and it carries one of the narrowest safe ranges of any supplement mineral -- a nutrient to reach adequacy on from food and a measured dose, never to megadose. Glutathione is the body's central intracellular antioxidant, and it is the system GGT is quietly reporting on. Rather than chasing glutathione directly, the mechanism-honest move is supplying its building blocks -- the sulfur amino acids -- and lowering the oxidative demand that depletes it. Omega-3 fats (EPA and DHA) belong here for their role in resolving inflammation and in cell-membrane function -- and this is a place to be scrupulously honest, because it is a compliance and a truth issue at once: for cancer risk specifically, the omega-3 evidence is null. A large trial found daily omega-3 did not lower cancer diagnoses, and umbrella reviews find no convincing effect on cancer risk.[1] Its value is in inflammation resolution and cardiovascular biology, which is a separate and better-supported matter. We say that plainly because the honest hierarchy is the whole point. Our view: for the immune terrain, a balanced foundation and real food beats a pile of single-nutrient megadoses almost every time -- especially for selenium and vitamin D, where the goal is adequacy inside a safe band, not a big isolated dose.

Vitamin D: the honest, two-sided read

Vitamin D deserves its own section because it is the marker most easily oversold in exactly this context, so we will state both sides and let the tension stand. On one side: low vitamin D status is associated with worse outcomes in a lot of observational data, and the vitamin has real, direct roles in immune function.[7] On the other side, the interventional evidence -- the trials that actually test giving people vitamin D -- is genuinely mixed. The large VITAL trial found that vitamin D supplementation did NOT significantly reduce cancer incidence, though it did find a reduction in cancer mortality that was more apparent when early follow-up years were excluded.[5] And a 2022 meta-analysis of 13 randomised trials found no effect on either incidence or mortality, in a population that was mostly already vitamin D replete.[6] The honest read, in our own words: vitamin D may relate to cancer mortality in some analyses, does not appear to reduce incidence, and the evidence is mixed across meta-analyses. That is a very different sentence from "vitamin D prevents cancer," which we do not say and which the evidence does not support. And the safety caveat that matters most, stated flatly: do not use vitamin D as a cancer-prevention strategy in place of guideline-recommended screening. Screening -- the tests a clinician actually recommends for your situation -- is the intervention with the outcome evidence. Correcting a genuine vitamin D deficiency is worthwhile for its own reasons; it is not a substitute for any of that. Education only, not medical advice.

The measurable loop: diet, practice, measure

Theory is easy to nod along to, so here is the everyday version of supporting a system your body already runs. None of this diagnoses, treats, or prevents anything -- it is the ordinary work of lowering inflammatory and oxidative burden and keeping the immune patrol well supplied, then measuring the terrain with a clinician rather than guessing. A note on the free tools that make this doable: our Diet Builder lets you load your plate with the nutrient-dense, anti-inflammatory foods that carry vitamin D, zinc, and selenium and see what each one feeds, and the Daily 3-6-9 is nine minutes of movement, mind, and meaning -- and the mind-and-meaning side is not decoration here, because sleep, stress, and even sense of purpose show up in immune measurements.

• Eat for lower terrain burden. The diet-and-oncology research frames protective, Mediterranean-style, nutrient-dense eating in terms of lower oxidative and inflammatory burden and better-functioning immune surveillance.[1] That is the mechanism-honest reason to eat this way -- a structure-and-function benefit to the body's normal defences, not a disease claim. Use the Diet Builder to make those foods a habit rather than a one-off.
• Move, sleep, and get outside. Regular movement and adequate sleep support normal immune function, and time in nature is measurable: a field study found that a forest-bathing trip increased natural killer cell activity, with effects lasting up to a week.[9] The Daily 3-6-9 exists to make the movement-and-stress side a small daily habit.
• Take meaning seriously. This is not soft -- it is measured. In over 7,000 adults over 50, a higher sense of purpose in life was linked to a higher percentage of naive CD4 T cells, a marker of healthier immune aging, independent of mood and health behaviours.[10] The immune patrol ages, and how a person lives appears to be part of how well it holds up.
• Then measure the terrain, with a clinician. The useful lab conversation is about the modifiable terrain markers -- inflammation, metabolic signalling, nutrient status -- and about which markers, if any, apply to you. That is a conversation to have with a clinical team, not a printout to interpret alone.

Terms, explained

This topic is full of abbreviations that hide how simple the underlying logic is. Here is the plain-language version of every term worth knowing.

• Immune surveillance -- the immune system's routine, everyday housekeeping: recognising and clearing cells that are damaged, aged, infected, or abnormal, as normal physiology. Not a test, not a treatment -- a process the body already runs.
• Natural killer (NK) cells -- the fast-acting innate arm of the patrol. They act on cells that look wrong without needing to be shown a specific target in advance.
• T cells / cytotoxic CD8 T cells -- the trained, targeted arm. They learn specific signatures, remember them, and act on cells displaying them.
• Immunosenescence -- the gradual aging of the immune system, which changes how well surveillance functions over a lifetime. A higher share of "naive" (untrained, ready) T cells is one marker of a younger-behaving immune system.
• Tumour marker -- a protein or genetic signal (PSA, CA-125, CEA, and the rest) a clinical team tracks to MONITOR a known cancer situation over time. Not a screening test, and not something to interpret from a single number at home.
• hs-CRP -- high-sensitivity C-reactive protein, a liver-made marker of systemic inflammation. It reflects background inflammatory burden and rises with any recent infection, injury, or hard exercise.
• IGF-1 -- insulin-like growth factor 1, a growth-signalling hormone set partly by growth hormone and partly by protein and calorie intake. Essential for normal muscle and bone; not a number to drive to a target.
• GGT -- gamma-glutamyl transferase, a liver enzyme that doubles as an oxidative-stress and glutathione-turnover marker. Nonspecific and sensitive to alcohol and metabolic health.
• Homocysteine -- an amino-acid by-product cleared by B12-, folate-, and B6-dependent pathways, making it a window on B-vitamin status; also raised by reduced kidney function.
• Terrain -- the umbrella idea running through this piece: the measurable conditions a body carries -- inflammation, metabolic strain, oxidative burden, nutrient status -- that the immune system's normal defences operate within.

The honest first moves

None of the above replaces the two steps that come before any supplement, and they are worth stating plainly. First, keep the lab in its lane. The tumour-marker half of this panel is a monitoring tool a clinical team orders and interprets -- it is not a screening test and not a self-diagnosis. If you are worried about cancer specifically, the honest move is a conversation with a clinician and the guideline-recommended screening for your situation, not a home panel and not a supplement plan. We say this as the firmest line in the piece: do not substitute anything here for that screening. Second, support the terrain the immune patrol runs in -- on its own merits. Correcting a genuine nutrient deficiency (vitamin D, zinc) is worth doing for immune function, bone, and muscle;[7][8] eating to lower inflammatory and oxidative burden supports the body's normal defences;[1] movement, sleep, nature, and a sense of purpose show up in immune measurements.[9][10] None of that is framed as preventing a disease, because that is not a claim we make or one the evidence supports -- it is the ordinary work of keeping a system your body already runs well supplied. Our view, to close: "cancer-adjacent is also immune system." The most useful thing a person can take from a panel like this is not fear and not a false sense of a home cancer test. It is a clearer picture of the terrain -- the inflammation, the metabolic signalling, the nutrient status the immune patrol depends on -- and the humility to read the monitoring markers only alongside the clinical team who ordered them. Education only, not medical advice. Structure and function of the body only.